News

Disrupting ribosome production – renewed potential for cancer therapy

Proliferating cells are in constant need of ribosomes, the molecular machines that help them produce proteins. Tumour cells, for instance, divide…

Read more
Alwin Köhler (c) Max Kropitz for Max Perutz Labs

Two Max Perutz Labs scientists elected as EMBO members

Every year EMBO (European Molecular Biology Organization) selects distinguished scientists who have made outstanding contributions in the field of the…

Read more

Andrea Pauli elected EMBO Member

IMP group leader Andrea Pauli is one of 64 newly elected members of the European Molecular Biology Organization (EMBO). The distinction brings the…

Read more

Valneva Completes Phase 3 Trial Recruitment for its Inactivated COVID-19 Vaccine Candidate

Valneva announced that it has completed recruitment for the pivotal Phase 3 trial of its inactivated, adjuvanted COVID-19 vaccine candidate,…

Read more

Colouring tumours reveals their bad influence

Red2Onco, an innovative genetic mouse model, allows to detect the very initial steps that lead to cancer development. Red2Onco’s multi-colour…

Read more

Radio programme: Every city has its own microbe fingerprint

Alexandra Graf from the FH Campus Vienna was invited to talk on the radio about her work on microbe fingerprints.

Read more
Fusion FATZ‐1 droplets , (c) Sponga et. al 2021

Building muscles from liquids – phase separation in the Z-disc

The lab of Kristina Djinovic-Carugo and their collaborators report the first structure of FATZ-1 in complex with a-actinin, two important proteins…

Read more
Group Leader Jörg Menche (c) Max Kropitz for Max Perutz Labs

Biology in the holodeck: exploring cellular interactions with virtual reality

Jörg Menche was born in Würzburg and studied physics in Germany and Brazil. In his PhD at the Max-Planck-Institute of Colloids and Interfaces he…

Read more

Elly Tanaka elected member of the Austrian Academy of Sciences

IMP Senior Scientist Elly Tanaka is one of 31 distinguished scientists that were elected to membership of the Austrian Academy of Sciences (ÖAW).

Read more

Harnessing Next Generation Sequencing to detect SARS-CoV-2 and prepare for the next pandemic

Researchers at the Vienna BioCenter designed a testing protocol for SARS-CoV-2 that can process tens of thousands of samples in less than 48 hours.…

Read more

©Mendjan/IMBA

Cardioids – Heartbeat, heartbreak and recovery in a dish

Self-organizing heart organoids developed at IMBA – Institute of Molecular Biotechnology of the Austrian Academy of Sciences – are also effective…

Read more

Valneva to Participate in the World’s First COVID-19 Vaccine Booster Trial in the UK

Valneva announced it will participate in a UK government-funded clinical trial looking at different COVID-19 ‘booster’ vaccines.

Read more

Read more